Dr Ines Moura
I performed my PhD studies at the Italian National Institute of Health (ISS-Italy) investigating mechanisms of antimicrobial resistance in C. difficile as part of a Marie Curie ITN. I later joined the National Reference Laboratory of Antimicrobial Resistance (INSA, Portugal) as postdoctoral researcher where I extended my knowledge in antimicrobial resistance to other Gram-positive and Gram-negative nosocomial pathogens. I then joined the Laboratory of Bacterial Evolution and Molecular Epidemiology (ITQB, Portugal) to investigate virulence factors in S. epidermidis using genomic and proteomic approaches.
Since 2016, I have been part of the Healthcare Associated Infection Research Group (HCAI) team, lead by Professor Mark Wilcox.
- Postdoctoral Researcher
Since joining the HCAI, I have extended my research interests to gut microbiome studies using 16S sequencing and qPCR. Some of these studies involve the in vitro model of the human colon used in our group to investigate drug induced dysbiosis of the intestinal microbiome and propensity to induce Clostridium difficile infection.
I have also taken part in a project funded by the Wellcome Trust and MRC, between the University of Oxford, PHE and the Wellcome Trust Sanger Institute, to establich how new technologies can be integrated into medical microbiology, which allowed me to extend my skills to WGS sequencing.
- PhD in Microbiology and Public Health Sciences
- MSc in Genetics
- BSc in Genetics and Biotechnology
Research groups and institutes
- Leeds Institute of Medical Research at St James's
- Healthcare Associated Infection Research Group